|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 413/14 | |
| C07D 403/04 | |||
| C07D 417/14 | |||
| A61K 31/4155 | |||
| A61P 43/00 |
| (11) | Patento numeris | 2797915 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12812498.9 |
| Europos patento paraiškos padavimo data | 2012-12-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-11-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-07-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/071654 |
| Data | 2012-12-26 |
| (87) | Numeris | WO 2013/101830 |
| Data | 2013-07-04 |
| (30) | Numeris | Data | Šalis |
| 201161580439 P | 2011-12-27 | US | |
| 201261654580 P | 2012-06-01 | US |
| (72) |
KIM, Charles, US
NAKAI, Takashi, US
MOORE, Joel, US
PERL, Nicholas, Robert, US
IM, G-yoon, Jamie, US
BARDEN, Timothy, Claude, US
IYENGAR, Rajesh, R., US
ZIMMER, Daniel, P., US
FRETZEN, Angelika, US
RENHOWE, Paul, Allan, US
|
| (73) |
Ironwood Pharmaceuticals, Inc.,
301 Binney Street, 2nd Floor, Cambridge, MA 02142,
US
|
| (54) | 2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure |
| 2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure |